Literature DB >> 28069657

Obesity and Heart Failure as Predictors of Failure in Outpatient Skin and Soft Tissue Infections.

Erin L Conway1, John A Sellick1,2, Kari Kurtzhalts1, Kari A Mergenhagen3.   

Abstract

The purpose of this study was to evaluate risk factors for failure of antibiotic treatment within 30 days for uncomplicated skin infections of outpatients treated in a Veterans Affairs hospital. A retrospective chart review of outpatients between January 2006 and July 2015 with an ICD-9 (International Statistical Classification of Diseases and Related Health Problems) code of cellulitis or abscess was included in the analysis. The primary outcome was success versus failure of the antibiotic, with failure defined as another antibiotic prescribed or hospitalization within 30 days for the original indication. A total of 293 patients were included in the final analysis, 24% of whom failed within 30 days. Obesity/overweight (body mass index [BMI] of >25 kg/m2) was identified in 83% of the overall population, with 16% of that population having a BMI greater than 40 kg/m2 An elevated mean BMI of 34.2 kg/m2 (P = 0.0098) was found in the subset of patients who failed oral antibiotics compared to a BMI of 31.32 kg/m2 in patients who were treated successfully. Additionally, the patients who failed had an increased prevalence of heart failure at 16% (P = 0.027). Using multivariate logistic regression, BMI and heart failure were determined to be significant predictors of antibiotic prescription failure. Each 10-kg/m2 unit increase in BMI was associated with a 1.62-fold-greater odds of failure. A diagnosis of heart failure increased the odds of failure by 2.6-fold (range, 1.1- to 5.8-fold). Outpatients with uncomplicated skin infections with an elevated BMI and heart failure were found to have increased odds of failure, defined as hospitalization or additional antibiotics within 30 days.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  antimicrobial; cellulitis; obesity; skin and soft tissue infections

Mesh:

Substances:

Year:  2017        PMID: 28069657      PMCID: PMC5328533          DOI: 10.1128/AAC.02389-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Risk factors for clinical failure in patients hospitalized with cellulitis and cutaneous abscess.

Authors:  Jenana Halilovic; Brett H Heintz; Jennifer Brown
Journal:  J Infect       Date:  2012-03-21       Impact factor: 6.072

Review 2.  Obesity and infection.

Authors:  Matthew E Falagas; Maria Kompoti
Journal:  Lancet Infect Dis       Date:  2006-07       Impact factor: 25.071

3.  Predictors of failure of empiric outpatient antibiotic therapy in emergency department patients with uncomplicated cellulitis.

Authors:  Daniel Peterson; Shelley McLeod; Karen Woolfrey; Andrew McRae
Journal:  Acad Emerg Med       Date:  2014-05       Impact factor: 3.451

Review 4.  Clinical pharmacokinetics in heart failure. An updated review.

Authors:  F V Shammas; K Dickstein
Journal:  Clin Pharmacokinet       Date:  1988-08       Impact factor: 6.447

5.  ED management of cellulitis: a review of five urban centers.

Authors:  S L Dong; K D Kelly; R C Oland; B R Holroyd; B H Rowe
Journal:  Am J Emerg Med       Date:  2001-11       Impact factor: 2.469

6.  Treatment failure in emergency department patients with cellulitis.

Authors:  Heather Murray; Ian Stiell; George Wells
Journal:  CJEM       Date:  2005-07       Impact factor: 2.410

7.  Population pharmacokinetics of clindamycin orally and intravenously administered in patients with osteomyelitis.

Authors:  Naïm Bouazza; Vincent Pestre; Vincent Jullien; Emmanuel Curis; Saïk Urien; Dominique Salmon; Jean-Marc Tréluyer
Journal:  Br J Clin Pharmacol       Date:  2012-12       Impact factor: 4.335

Review 8.  The epidemic of obesity.

Authors:  Cynthia J Stein; Graham A Colditz
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

9.  Antibiotic prophylaxis for surgery in morbidly obese patients.

Authors:  R A Forse; B Karam; L D MacLean; N V Christou
Journal:  Surgery       Date:  1989-10       Impact factor: 3.982

10.  Antibacterial prescribing in primary care.

Authors:  Irene Petersen; Andrew C Hayward
Journal:  J Antimicrob Chemother       Date:  2007-08       Impact factor: 5.790

View more
  8 in total

1.  Treatment failure definitions for non-purulent skin and soft tissue infections: a systematic review.

Authors:  Krishan Yadav; Avik Nath; Kathryn N Suh; Lindsey Sikora; Debra Eagles
Journal:  Infection       Date:  2019-08-05       Impact factor: 3.553

2.  Treatment Duration and Associated Outcomes for Skin and Soft Tissue Infections in Patients With Obesity or Heart Failure.

Authors:  Claudia Ihm; Jesse D Sutton; Tristan T Timbrook; Emily S Spivak
Journal:  Open Forum Infect Dis       Date:  2019-05-07       Impact factor: 3.835

Review 3.  Antimicrobial Dosing in Specific Populations and Novel Clinical Methodologies: Obesity.

Authors:  Manjunath P Pai
Journal:  Clin Pharmacol Ther       Date:  2021-02-28       Impact factor: 6.875

4.  Pharmacokinetics and Pharmacodynamics of High-Dose Piperacillin-Tazobactam in Obese Patients.

Authors:  John J Veillette; S Alexander Winans; Victoria K Maskiewicz; James Truong; Ronald N Jones; Steven C Forland
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2021-03-20       Impact factor: 2.569

5.  Cellulitis in adult patients: A large, multicenter, observational, prospective study of 606 episodes and analysis of the factors related to the response to treatment.

Authors:  Julio Collazos; Belén de la Fuente; Alicia García; Helena Gómez; C Menéndez; Héctor Enríquez; Paula Sánchez; María Alonso; Ian López-Cruz; Manuel Martín-Regidor; Ana Martínez-Alonso; José Guerra; Arturo Artero; Marino Blanes; Javier de la Fuente; Víctor Asensi
Journal:  PLoS One       Date:  2018-09-27       Impact factor: 3.240

Review 6.  Metabolic programming of macrophage functions and pathogens control.

Authors:  Sue-Jie Koo; Nisha J Garg
Journal:  Redox Biol       Date:  2019-04-20       Impact factor: 11.799

7.  Sphingobacterium spiritivorum bacteremia due to cellulitis in an elderly man with chronic obstructive pulmonary disease and congestive heart failure: a case report.

Authors:  Arata Hibi; Yuka Kumano
Journal:  J Med Case Rep       Date:  2017-09-30

8.  Real-Life Evidence for Tedizolid Phosphate in the Treatment of Cellulitis and Wound Infections: A Case Series.

Authors:  Sergey Shlyapnikov; Arturo Jauregui; Nana N Khachatryan; Asok Kurup; Javier de la Cabada-Bauche; Hoe N Leong; Li Li; Mark H Wilcox
Journal:  Infect Dis Ther       Date:  2018-07-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.